SI0770070T1 - Method for preparing 4-acetoxy-2alpha-benzoyloxy-5alpha,20-epoxy-1,7beta,10beta-trihydroxy-9-oxo-tax-11-en-13alpha-yl(2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate trihydrate - Google Patents

Method for preparing 4-acetoxy-2alpha-benzoyloxy-5alpha,20-epoxy-1,7beta,10beta-trihydroxy-9-oxo-tax-11-en-13alpha-yl(2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate trihydrate

Info

Publication number
SI0770070T1
SI0770070T1 SI9530138T SI9530138T SI0770070T1 SI 0770070 T1 SI0770070 T1 SI 0770070T1 SI 9530138 T SI9530138 T SI 9530138T SI 9530138 T SI9530138 T SI 9530138T SI 0770070 T1 SI0770070 T1 SI 0770070T1
Authority
SI
Slovenia
Prior art keywords
beta
butoxycarbonylamino
benzoyloxy
trihydroxy
tax
Prior art date
Application number
SI9530138T
Other languages
English (en)
Slovenian (sl)
Inventor
Jean-Rene Authelin
Jacques Doveze
Elie Fouque
Bernadette Mandard
Isabelle Taillepied
Original Assignee
Rhone-Poulenc Rorer S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9465183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0770070(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone-Poulenc Rorer S.A. filed Critical Rhone-Poulenc Rorer S.A.
Publication of SI0770070T1 publication Critical patent/SI0770070T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
SI9530138T 1994-07-08 1995-07-07 Method for preparing 4-acetoxy-2alpha-benzoyloxy-5alpha,20-epoxy-1,7beta,10beta-trihydroxy-9-oxo-tax-11-en-13alpha-yl(2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate trihydrate SI0770070T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9408479A FR2722191B1 (fr) 1994-07-08 1994-07-08 Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
EP95925022A EP0770070B1 (fr) 1994-07-08 1995-07-07 Procede de preparation du trihydrate du (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1,7beta,10beta-trihydroxy-9-oxo-tax-11-en-13alpha-yle
PCT/FR1995/000910 WO1996001815A1 (fr) 1994-07-08 1995-07-07 PROCEDE DE PREPARATION DU TRIHYDRATE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1,7β,10β-TRIHYDROXY-9-OXO-TAX-11-EN-13α-YLE

Publications (1)

Publication Number Publication Date
SI0770070T1 true SI0770070T1 (en) 1998-12-31

Family

ID=9465183

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530138T SI0770070T1 (en) 1994-07-08 1995-07-07 Method for preparing 4-acetoxy-2alpha-benzoyloxy-5alpha,20-epoxy-1,7beta,10beta-trihydroxy-9-oxo-tax-11-en-13alpha-yl(2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate trihydrate

Country Status (38)

Country Link
US (1) US6022985A (cg-RX-API-DMAC7.html)
EP (1) EP0770070B1 (cg-RX-API-DMAC7.html)
JP (1) JP3753155B2 (cg-RX-API-DMAC7.html)
KR (1) KR100391753B1 (cg-RX-API-DMAC7.html)
CN (1) CN1067996C (cg-RX-API-DMAC7.html)
AT (1) ATE171702T1 (cg-RX-API-DMAC7.html)
AU (1) AU706519B2 (cg-RX-API-DMAC7.html)
BR (1) BR9508789A (cg-RX-API-DMAC7.html)
CA (1) CA2193531C (cg-RX-API-DMAC7.html)
CO (1) CO4410189A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ284695B6 (cg-RX-API-DMAC7.html)
DE (1) DE69505128T2 (cg-RX-API-DMAC7.html)
DK (1) DK0770070T3 (cg-RX-API-DMAC7.html)
DZ (1) DZ1905A1 (cg-RX-API-DMAC7.html)
ES (1) ES2121404T3 (cg-RX-API-DMAC7.html)
FI (1) FI119246B (cg-RX-API-DMAC7.html)
FR (1) FR2722191B1 (cg-RX-API-DMAC7.html)
GR (1) GR3027558T3 (cg-RX-API-DMAC7.html)
HU (1) HU220634B1 (cg-RX-API-DMAC7.html)
IL (1) IL114274A (cg-RX-API-DMAC7.html)
IN (1) IN183947B (cg-RX-API-DMAC7.html)
IS (1) IS2032B (cg-RX-API-DMAC7.html)
MA (1) MA23606A1 (cg-RX-API-DMAC7.html)
MX (1) MX9700173A (cg-RX-API-DMAC7.html)
MY (1) MY118481A (cg-RX-API-DMAC7.html)
NO (1) NO314500B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ289455A (cg-RX-API-DMAC7.html)
PE (1) PE8697A1 (cg-RX-API-DMAC7.html)
PL (1) PL179876B1 (cg-RX-API-DMAC7.html)
RU (1) RU2126397C1 (cg-RX-API-DMAC7.html)
SI (1) SI0770070T1 (cg-RX-API-DMAC7.html)
SK (1) SK280520B6 (cg-RX-API-DMAC7.html)
TN (1) TNSN95071A1 (cg-RX-API-DMAC7.html)
TW (1) TW419473B (cg-RX-API-DMAC7.html)
UA (1) UA51624C2 (cg-RX-API-DMAC7.html)
UY (1) UY23991A1 (cg-RX-API-DMAC7.html)
WO (1) WO1996001815A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA955646B (cg-RX-API-DMAC7.html)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL132323A0 (en) 1997-04-28 2001-03-19 Rhone Poulenc Rorer Sa Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
FR2794771B1 (fr) 1999-06-11 2001-08-10 Aventis Pharma Sa Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
US6853921B2 (en) 1999-07-20 2005-02-08 Halliburton Energy Services, Inc. System and method for real time reservoir management
US6266619B1 (en) * 1999-07-20 2001-07-24 Halliburton Energy Services, Inc. System and method for real time reservoir management
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
US6891050B2 (en) * 2001-08-10 2005-05-10 Dabur India Limited Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
US6881852B2 (en) * 2002-02-05 2005-04-19 Dabur India Limited Process of purification of paclitaxel and docetaxel
US7247738B2 (en) * 2002-05-07 2007-07-24 Dabur India Limited Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
US6900342B2 (en) * 2002-05-10 2005-05-31 Dabur India Limited Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
US6838569B2 (en) * 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
US7584165B2 (en) * 2003-01-30 2009-09-01 Landmark Graphics Corporation Support apparatus, method and system for real time operations and maintenance
US8703982B2 (en) 2003-03-17 2014-04-22 Phyton Holdings Llc Purification of taxanes
CN1268619C (zh) * 2003-05-08 2006-08-09 上海迪赛诺化学制药有限公司 多烯紫杉醇三水化合物的制备方法
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
EP1947094A3 (en) 2003-12-12 2009-02-18 Quiral Quimica Do Brasil Process for the preparation of taxane derivatives
US7142986B2 (en) * 2005-02-01 2006-11-28 Smith International, Inc. System for optimizing drilling in real time
CN100420681C (zh) * 2005-04-29 2008-09-24 上海奥锐特国际贸易有限公司 多烯紫杉醇三水物的制备方法
TR200801336T1 (tr) 2005-08-31 2008-08-21 Abraxis Bioscience, Inc. Kararlılığı artmış zayıf su çöznurluğune sahip ilaçların preparasyonuna yönelik kompozisyonlar ve yöntemler.
KR101457834B1 (ko) * 2005-08-31 2014-11-05 아브락시스 바이오사이언스, 엘엘씨 증가된 안정성을 가진 수 난용성 약물의 조성물 및 제조 방법
WO2007044950A2 (en) * 2005-10-12 2007-04-19 Sicor, Inc. Crystalline forms of docetaxel and processes for their preparation
KR100995390B1 (ko) 2006-01-02 2010-11-19 주식회사 삼양제넥스 무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법
AU2007207497B8 (en) * 2006-01-20 2013-05-16 Landmark Graphics Corporation Dynamic production system management
KR20080100264A (ko) * 2006-03-21 2008-11-14 닥터 레디스 레보러터리즈 리미티드 도세탁셀의 다형체와 그 제조방법
JP2010506932A (ja) * 2006-10-20 2010-03-04 シノファーム シンガポール ピーティーイー,リミテッド 結晶性の無水ドセタキセルの製造方法
KR100868116B1 (ko) * 2007-04-09 2008-11-10 한미약품 주식회사 도세탁셀·모노프로필렌글라이콜 내포화합물 및 이의제조방법
KR100878455B1 (ko) * 2007-04-10 2009-01-13 한미약품 주식회사 안정한 무수결정형 도세탁셀 및 이의 제조방법
EP2173732A4 (en) * 2007-07-04 2011-09-07 Reddys Lab Ltd Dr PROCESSES FOR THE PREPARATION OF DOCETAXEL AND POLYMORPHIC
EP2080763A1 (en) * 2008-01-18 2009-07-22 INDENA S.p.A. Crystalline form I of ortataxel
DK2080764T3 (da) 2008-01-18 2012-09-24 Indena Spa Faste former af ortataxel
PL388144A1 (pl) 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
ES2621613T3 (es) 2009-11-04 2017-07-04 Emcure Pharmaceuticals Limited Un proceso mejorado para la preparación de derivados de taxano
CA2798180A1 (en) 2010-05-03 2011-11-10 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
WO2012160568A1 (en) * 2011-05-23 2012-11-29 Shilpa Medicare Limited Process for preparing docetaxel trihydrate polymorph
RS58146B1 (sr) 2011-09-08 2019-02-28 Univ New York Onkolitički herpes simpleks virus i njegova terapeutska upotreba
US9745631B2 (en) 2011-12-20 2017-08-29 Dana-Farber Cancer Institute, Inc. Methods for diagnosing and treating oncogenic kras-associated cancer
CA2869460C (en) 2012-04-04 2018-05-15 Halozyme, Inc. Combination therapy with an anti-hyaluronan agent and a tumor-targeted taxane
CA2874521A1 (en) 2012-05-24 2013-11-28 Dana-Farber Cancer Institute, Inc. Targeting the glutamine to pyruvate pathway for treatment of oncogenic kras-associated cancer
WO2014014518A1 (en) 2012-07-18 2014-01-23 Dana-Farber Cancer Institute, Inc. Methods for treating, preventing and predicting risk of developing breast cancer
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
WO2014149871A1 (en) 2013-03-14 2014-09-25 Icahn School Of Medicine At Mount Sinai Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer
WO2015050844A1 (en) 2013-10-01 2015-04-09 Dana-Farber Cancer Institute, Inc. Methods of treating cancer with atovaquone-related compounds
US10350264B2 (en) 2014-03-27 2019-07-16 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating NCOA4-mediated autophagic targeting of ferritin
MA39818A (fr) 2014-03-30 2017-02-08 Benevir Biopharm Inc Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
EP3307330B1 (en) 2015-06-15 2021-03-10 New York University Method of treatment using oncolytic viruses
WO2019222435A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides

Also Published As

Publication number Publication date
BR9508789A (pt) 1997-10-21
TW419473B (en) 2001-01-21
US6022985A (en) 2000-02-08
CO4410189A1 (es) 1997-01-09
PL318195A1 (en) 1997-05-26
IS4411A (is) 1997-01-07
UA51624C2 (uk) 2002-12-16
AU2930595A (en) 1996-02-09
MA23606A1 (fr) 1996-04-01
NO314500B1 (no) 2003-03-31
KR100391753B1 (ko) 2004-02-11
RU2126397C1 (ru) 1999-02-20
HU9700041D0 (en) 1997-02-28
HU220634B1 (hu) 2002-03-28
DZ1905A1 (fr) 2002-02-17
FR2722191B1 (fr) 1996-08-23
ZA955646B (en) 1996-02-21
FR2722191A1 (fr) 1996-01-12
ES2121404T3 (es) 1998-11-16
NO970007D0 (no) 1997-01-02
CN1067996C (zh) 2001-07-04
MX9700173A (es) 1997-04-30
CA2193531C (fr) 2006-12-05
FI119246B (fi) 2008-09-15
PE8697A1 (es) 1997-03-26
NO970007L (no) 1997-01-02
CA2193531A1 (fr) 1996-01-25
CZ284695B6 (cs) 1999-02-17
DE69505128T2 (de) 1999-04-01
FI970069A0 (fi) 1997-01-07
MY118481A (en) 2004-11-30
SK697A3 (en) 1997-06-04
UY23991A1 (es) 1995-09-20
DE69505128D1 (de) 1998-11-05
IL114274A0 (en) 1995-10-31
HUT76833A (en) 1997-11-28
JP3753155B2 (ja) 2006-03-08
DK0770070T3 (da) 1999-03-01
IL114274A (en) 1999-04-11
JPH10502627A (ja) 1998-03-10
AU706519B2 (en) 1999-06-17
CN1151741A (zh) 1997-06-11
PL179876B1 (pl) 2000-11-30
IS2032B (is) 2005-08-15
EP0770070B1 (fr) 1998-09-30
WO1996001815A1 (fr) 1996-01-25
FI970069L (fi) 1997-01-07
ATE171702T1 (de) 1998-10-15
SK280520B6 (sk) 2000-03-13
GR3027558T3 (en) 1998-11-30
TNSN95071A1 (fr) 1996-02-06
CZ3597A3 (en) 1997-04-16
EP0770070A1 (fr) 1997-05-02
IN183947B (cg-RX-API-DMAC7.html) 2000-05-20
NZ289455A (en) 1997-12-19
KR970704721A (ko) 1997-09-06

Similar Documents

Publication Publication Date Title
GR3027558T3 (en) Method for preparing 4-acetoxy-2alpha-benzoyloxy-5alpha,20-epoxy-1,7beta,10beta-trihydroxy-9-oxo-tax-11-en-13alpha-yl(2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate trihydrate
MD1976B2 (ro) Produs din tutun sau articole similare produselor din tutun conţinând substanţe naturale cu proprietăţi antioxidante şi procedeu de obţinere a acestora
ATE216576T1 (de) Vehrfahren zur herstellung von beta-lactam antibiotikum enthaltenden oralen dosisformen
CZ255793A3 (en) Process for preparing an admixture comprising micro-organisms with increased content of at least one trace element
EP0714877A3 (en) Process for the preparation of alpha-phenylethyl alcohol
DE69507150D1 (de) Gelbildende präparate, die optisch angereicherte gelbildner enthalten
JPS57144986A (en) Preparation of lipid having high content of gamma-linolenic acid
JPS57145896A (en) Glycolipid and its preparation by fermentation
PL310207A1 (en) Nisatidin containing pharmaceutical agent, method of obtaining nisatidin in its specific form and specific form of nisatidin as such
ES485529A1 (es) Un procedimiento para la produccion de ravidomicina
MD460G2 (ro) Procedeu de sinteză a cianocobalaminei
SU1791978A1 (ru) Кормовая добавка
HUT64291A (en) Method for racemizing non-racemic 3-oxo-cyclopentane-carboxylic acid or 3-oxo-cyclohexanecarboxylic acid, as well as their esters produced with alkohols containing 1 to 6 carbon atoms
HUT55735A (en) Process for producing new plant cultiviting medium by using mainly natural waste materials
OA06266A (fr) Procédé de préparation d'un extrait de globularia utile notamment en thérapeutiques.
SU1831779A3 (ru) Кормовой белковый продукт
MX9605277A (es) Procedimiento para obtener carboxilatos croman.
UA12584A (uk) Спосіб одержаhhя продуктів мікробіологічhого сиhтезу